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Evaluation of an Absorbable Collagen
Membrane in Treating Class II
Furcation Defects
Horn-Lay Wang,* Robert  . O'Neal,* Clifford L. Thomas/ Yu Shyr/ and
R. Lamont MacNeil*
Recent research has focused upon the utilization of an absorbable collagen mem-
brane in guided tissue regeneration (GTR). Concern exists as to whether this type of
membrane is beneficial in the treatment of periodontal defects. The purpose of this study
was to evaluate the effect of a type I bovine collagen membrane on treatment of Class
II furcation defects. Twelve systemically healthy patients (six male and six female, ages
32 to 68) were treated. Each had bilateral mandibular furcation defects with attachment
loss >6 mm. Prior to surgery all patients completed initial therapy including scaling and
root planing. At the time of the surgery, teeth were randomly assigned to either a control
(flap debridement alone) or test (flap debridement plus collagen membrane) group. Data
were collected on the day of surgery, and 2, 4, and 6 months post-surgery and at the 12
month re-entry surgery. Clinical measurements included probing depth (PD), clinical
attachment level (CAL), gingival recession (GR), Stent to base of defect (SB), crestal
bone to base of defect (CB), width of defect, and mobility. Statistical analysis was per-
formed utilizing the paired t test. Both control and test groups demonstrated significant
(P< 0.05) improvement at 12 months re-entry in PD, CAL, SB, and CB when compared
to the presurgery status. While there is no significant difference in PD, CAL, GR, width
of defect, and mobility between control and test groups, sites treated with the collagen
membrane had significantly higher bone fill (SB and CB) at re-entry. A significant im-
provement of furcation horizontal bone repair and defect improvement was noted in the
collagen membranes-treated sites as compared to the presurgery status. No foreign body
reaction was observed in either group during this study. This study suggests that the use
of absorbable collagen membrane may have beneficial effects in the treatment of Class
II furcal defects. J Periodontol 1994; 65:1029-1036.
Key Words: Collagen therapeutic use; furcation therapy; guided tissue regeneration;
membranes, barrier; randomized clinical trial.
Guided tissue regeneration (i.e., epithelial exclusion and se-
lective repopulation of the root surface by multipotential
cells) utilizing non-resorbable occlusive membranes has be-
come an accepted mode of therapy in periodontics.12 Al-
though proven efficacious in promoting new connective tis-
sue attachment, non-resorbable membranes are not without
their shortcomings. For example, recession with bacterial
contamination is a common clinical finding.3 In addition,
the need for a second surgical procedure to retrieve the
membrane may also disrupt healing. We have been con-
ducting research on an absorbable barrier composed of type
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I collagen. Collagen has a number of properties which make
it practical for use as a barrier.4 7
Collagen is the most abundant protein in the body and
the main constituent of periodontal connective tissue. It
comprises approximately 30% of the human body and func-
tions as the extracellular framework for all multi-cellular
animals. The rationale for using collagen as a barrier is
based on the following: First, collagen possesses hemostatic
properties.8 Wikesjö et al. have indicated that in order for
regeneration to occur, the developing clot must form and
adhere to the root surface thereby facilitating proper wound
maturation.9 Because collagen is a hemostatic agent by vir-
tue of its ability to aggregate platelets, it may further fa-
cilitate wound maturation by enhancing the initial blood
clot and fibrin linkage formation. This concept is supported
by Haney et al. who indicated that clot stabilization, wound
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stability, space provision, epithelial cell exclusion, and
complete gingival coverage are critical factors for the suc-
cess of the GTR procedure.10 Second, a collagen membrane,
once infiltrated by vascular channels, may serve as a lattice
for migrating periodontal ligament fibroblasts.11 Third, col-
lagen has been found to be chemotactic for fibroblasts in
vitro,12 a property that may enhance cell migration into the
space formed between the root surface and the collagen
membrane. Clinical trials and animal studies have shown
most collagen membranes to be effective in inhibiting ep-
ithelial migration and promoting new connective tissue at-
tachment.1314 Fourth, collagen can be formed into many
shapes and can easily be manipulated and adapted to the
root surface. Fifth, collagen is a weak immunogen.15 Sixth,
collagen is a cross-linked material which, is bioabsorbable,
eliminating the need for re-entry surgery to remove it.16 In
total, these properties suggest that collagen may have ap-
plications as a barrier material for use in regeneration ther-
apy. Thus, the following study was designed to evaluate the
effect of a type I bovine collagen membrane in treatment
of Class II furcation defects.
MATERIALS AND METHODS
Patients
The research protocol herein described was approved by
the Human Subjects Review Committee at the School of
Dentistry, The University of Michigan. Twelve systemi-
cally healthy patients (ages 32 to 68), six males and six
females, were included in the study. The following criteria
were used to select the patients for this clinical study: 1)
evidence of advanced Periodontitis; 2) bilateral Class II
mandibular furcation defects exhibiting attachment loss >6
mm; 3) radiographie evidence of a Class II mandibular mo-
lar defect; 4) excellent systemic health; 5) no antibiotic
therapy in the past 6 months; and 7) no periodontal surgery
in the past 12 months. Informed consent from all subjects
who met the criteria and agreed to participate in the study
were obtained. Patients entered the study either directly af-
ter a standard preparation stage (i.e., oral hygiene instruc-
tion, scaling and root planing, and other initial disease con-
trol procedures) or upon the decision that surgical interven-
tion was needed during maintenance therapy.
Measurements
Clinical data including probing depths (PD) of the peri-
odontal defects, gingival recession (GR), mobility and
plaque (PI) and gingival (Gl) indices were collected at
baseline (one week prior to the surgery) and 2, 4 and 6
months post surgery. PD were obtained using a North Car-
olina 15 mm probe: the deepest point at six sites of selected
teeth was recorded. GR was measured from the cemento-
enamel junction (CEJ) to the free gingival margin. Tooth
mobility was detected utilizing Miller's classification (0 =
no mobility; 1 = the first distinguishable sign of movement
greater than normal; 2 = movement of 1 mm from normal
position in any direction; and 3 = movement of more than
1 mm in any direction).17 PI was recorded according to
Silness and Löe.18 Gl was measured using the criteria de-
scribed by Löe and Silness.19 Additional clinical measure-
ments were performed at the time of periodontal surgery
and at one year re-entry surgery. Clinical attachment levels
(CAL) were measured using a pre-fabricated acrylic Stent
and a North Carolina 15 mm probe; the Stent was grooved
at the time of surgery to record the orientation of the probe.
When placed in the osseous defect, an occlusal ledge served
as an occlusal landmark. The following measurements were
made: SB, stent to the base of defect, stent to the free gin-
gival margin; CB, crest of bone to base of defect; and buc-
colingual/mesiodistal morphology of the furcation defects
(Fig- 1).
Surgical Protocol
All surgical procedures were performed by the same peri-
odontist. Bilateral mandibular furcation defects were ran-
domly assigned by coin toss to receive either flap debride-
ment plus collagen membrane (test) or flap debridement
alone (control) before the defects were debrided. The sur-
gical procedure involved the elevation of a full thickness
mucoperiosteal flap with intracrevicular incisions, preserv-
ing as much keratinized tissue as possible. The furcation
defects were debrided and all root surfaces were completely
scaled and root planed by hand, ultrasonic, and rotating
instrumentation. The test material was a collagen mem-
Stent
groove
Figure 1. Method used to analyze the furcation defect. (I) occlusal surface
of stent to a line drawn from the mesial to distal at the base of the defect
(BD); (2) crest of bone (AC) to base of the defect (BD); (3) horizontal
probing depth (horizontal PD) from a line tangential to the root surface
to the horizontal extent of the defect; (4) vertical probing depth (vertical
PD) measures the line from the mesial to the distal at the bottom of the
furcation defect (modified from Paul, et al.23).
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Table 1. Clinical Parameters Comparison Between Collagen Treated and Flap Debridement Control
Sites (mean ± standard error) at Different Time Periods (n = 12 per group)
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Table 2. Clinical Measurements (mm) for Collagen and Flap





(mean ± SE) Difference
Probing depths
Attachment level
Stent to free gingival
margin
Stent to base of defect






6.92 ±0.79 6.92 ±2.43





















No statistically-significant difference =  <0.05.
brane8 prepared from purified bovine Achilles tendon in a
chemically cross-linked form and supplied in individual 18
mm X 38 mm X 0.15-0.22 mm sterile pieces. The material
was individually cut to proper dimension and then placed
over the defect extending 2 mm beyond the edge of the
furcation defect. The membrane was not sutured unless the
size of the defect necessitated such procedures. Any sutur-
ing of the membrane was accomplished with 5-0 chromic
gut sutures. The flap was subsequently sutured securely to
its original position with 4-0 black silk sutures, with care
to ensure that no portion of the membrane was left exposed
on the day of surgery. On the control side all surgical pro-
cedures were identical, except that no membrane was
placed. All patients received routine written and oral post-
operative instructions and were prescribed doxycycline 100
mg/day for 2 weeks. Each patient was instructed to rinse
with 0.12% Chlorhexidine gluconate11 for a period of 6
weeks. Sutures were removed 7 to 10 days after the surgery
and any change in position of the membrane noted. Patients
returned weekly for 4 weeks for observation of any adverse
tissue reactions. Patients were then seen at 2, 4, and 6
months post-surgery for Gl, PI, PD, and GR recording; tis-
sue evaluation; plaque debridement; and oral hygiene
review.
One Year Re-Entry Surgery
At the end of 12 months, the patients were scheduled for
re-entry surgery. Clinical measurements (GI, PI, PD, CAL,
§BioMend (formerly Periobarrier), Calcitek Inc., Carlsbad, CA.
"Peridex, Procter & Gamble, Cincinnati, OH.
Stent to the free gingival margin, SB, CB, and mobility) of
the involved tooth were recorded prior to the surgery. Sur-
gical re-entry consisted of sulcular incisions to preserve at-
tached gingiva and interdental papillae. Full-thickness mu-
coperiosteal flaps were designed to expose the previously
treated furcation areas for clinical photographs and meas-
urements as previously described. Flaps were then replaced
and sutured. Patients were seen at one week post-surgery
for suture removal, and then placed on a closely supervised
3-month schedule for supportive periodontal treatment.
Statistical Analysis
The data were organized, presented as means ± standard
error and analyzed using the SAS system. Repeated meas-
ures analysis of variance (ANOVA) was used to evaluate
changes in clinical parameters within groups at different
times. The paired r-test was utilized to compare the clinical
measurements between control and test groups at each time
period. Significance was reported at the  = 0.05 level.
RESULTS
Twelve patients (mean age 46.42 ±9.15) with bilateral sim-
ilar furcation defects were studied. During the course of
this study, no adverse tissue reaction, infections, or delayed
healing were reported. As shown in Table 1, GI and PI
decreased dramatically in both test and control sites at two
months post-surgery. This noticeable downward shift was
maintained throughout the experimental (12 month) period.
The mean PD was reduced significantly at 2, 4, 6, and 12
months post-surgery when compared to baseline in both
groups. No significant differences of GI, PI, and mean PD
were noted between the test and control sites at any time
point.
Only mid-buccal or -lingual furca measurements from
stent to free gingival margin, SB, and CB were used for
statistical analysis. No differences were noted at baseline
between collagen treated sites and flap debridement control
sites for any clinical parameters (Table 2). Table 3 presents
a comparison of clinical measurements for test and control
sites at one year re-entry. A statistically significant variance
was observed in CB (crestal bone to base of defect) for test
(collagen) site when compared to control site at one year
re-entry. Other parameters, while showing positive trends
and differences, did not demonstrate statistically significant
changes.
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Table 3. Clinical Measurements (mm) for Collagen and Flap
Debridement Control Sites at One Year Re-Entry (n = 12 per
group)
Table 5. Percentage Reduction in Vertical Bone Fill and Horizontal





(mean ± SE) Difference
Probing depths
Attachment level
Stent to free gingival
margin
Stent to base of defect






























'Statistically significant difference =  <0.05.
Table 4. Clinical Changes in Class II Furcation Invasions (mm) One
Year After Treatment With and Without Collagen Barrier





(mean ± SE) Difference
Probing depths
Attachment level
Stent to free gingival
margin
Stent to base of defect

















0.38 ±0.23 0.21 ±0.28









*Statistically significant between baseline and one year reentry at  
<0.05.
•Statistically significant difference =  <0.05.
When the one year re-entry values were compared to the
baseline measurements, both treatment modalities showed
significant reduction (P <0.05) in all clinical parameters
from baseline (Table 4). The mean probing depth improve-
ment for the collagen barrier-treated defects was 2.84 mm
as compared to 1.92 mm for the controls. Collagen-treated
sites showed statistically significant gain of attachment
(1.67 mm), whereas there was no significant gain for the
controls (0.67 mm). No difference was noted between test
and control sites with regard to gingival recession. The col-
lagen barrier sites showed an improvement in defect fill
(stent to base of defect) (2.50 mm vs. 1.50 mm) and vertical
bone fill (crest of bone to base of defect) (2.83 mm vs. 1.50
mm) which was statistically significant in comparison to
the control sites. When considering the furcation measure-
ments, the sites treated with collagen membrane showed a
significant improvement in horizontal probing depths and
defect improvement as compared to the baseline. Defect
area improvement was calculated from this formula: defect
area improvement = (1/2 X Horizontal™"3' X Verticalinitial)
-
(1/2 X Horizontal"1-0"^ X Verticalrccntr"). No significant
Clinical








0 (0%) 2 (16.7%) 10 (83.3%)
4 (33.3%) 3 (25%) 5 (41.7%)
2 (16.7%) 6 (50%) 4 (33.3%)
Control 1 (8.3%) 6 (50%) 2 (16.7%) 3 (25%)
improvement was noted on the control treated sites when
compared to the pre-surgery measurements.
At re-entry, the percent of improvement in vertical bone
fill and furcation horizontal (bucco-lingual width) probing
depth was calculated for each treatment site. The data were
grouped in 25% increments (Table 5). The collagen sites
had 10 of the 12 sites with vertical bone fill greater than
50% as compared to 5 out of 12 in the control groups. Ten
furcations treated with collagen membrane showed a re-
duction in the horizontal probing depth greater than 25%,
while less than half (5) of the controls demonstrated the
same.
No adverse gingival tissue reactions were observed. In
addition, at no time was displacement of the collagen mem-
brane noted. None of the treated teeth had a change in mo-
bility at one year and no significant differences were noted
between groups. Surgical procedures and treatment results
are illustrated in Figures 2 and 3.
DISCUSSION
The use of collagen as a barrier to enhance cell/tissue re-
generation to a previously diseased root has gained consid-
erable attention recently.4-7 Here we describe the use of a
bioabsorbable type I collagen membrane derived from bo-
vine tendon. This membrane is biodegradable and its ab-
sorption rate is controlled by its degree of crosslinking, with
an average retention time of 6 to 7 weeks.20 The membrane
is semipermeable with a pore size of 0.004 µ  and can
prevent epithelial cell penetration while permitting passage
of nutrients. This study was designed to evaluate the barrier
in treating Class II mandibular molar furcation defects in
humans. The results of this one year re-entry clinical trial
indicate that the placement of type I bovine collagen in
Class II furcations results in significantly greater defect fill
(2.50 mm vs. 1.50 mm) and vertical bone fill (2.83 mm vs.
1.50 mm) when compared to control sites. Similar results
were reported by Blumenthal,21 who showed that sites
treated with a different collagen membrane gained vertical
open probing new attachment at 12 months re-entry when
compared to baseline. Our results are also in agreement
with the 3 months re-entry study by Van Swol et al.,6 who
reported that collagen treated sites had significantly higher
vertical bone fill (from CEJ to base of the bony defect)
when compared to the control groups. Similar findings were
also reported by Chung et al.7 in their one year study.
When both treatment modalities (with and without col-
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Figure 2. Demonstration of clinical placement of collagen membrane in a molar tooth (#30) with Class II furcation involvement. A. pre-surgery; B.
buccal initial incision designed to preserve papillary tissue with a vertical releasing incision on the mesial; C. surgical exposure of a class II furcation
defect with evidence of cervical enamel projection; D. low speed diamond bur to remove the cervical enamel projection; E. membrane trimmed; F.
membrane placed without suture.
lagen barrier) were compared, both showed significant im-
provement in clinical measurements from baseline (Table
4). The mean probing depth improvement and attachment
gain for the collagen barrier treated defects was 2.84 mm
and 1.67 mm, respectively, as compared to 1.92 mm and
0.67 mm for the control sites. Although collagen-treated
sites tended to respond more favorably, surgical interven-
tion either with or without membrane placement resulted in
reducing probing depth at furcal sites. Similar results have
been reported by Paul et al.22
The positive effect of collagen membrane treatment on
furcation sites was most evident in improvement in hori-
zontal probing depth and defect fill. The sites treated with
collagen membrane showed a significant improvement in
horizontal bone repair (2.04 ±0.43 mm) and defect im-
provement (3.90 ±0.88 mm) compared to baseline. How-
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Figure 2. (Continued) G. tissues sutured; H. one-week post-surgery healing; I. one-year post surgery healing; J. one-year re-entry showed newly formed
tissue; K. surgical exposure of the flap debridement treated control site; L. one year re-entry of the flap debridement treated control site indicated no
gain of the newly formed tissue.
ever, no significant improvement was noted on the control
treated sites (1.08 ±0.61 mm and 2.07 ±1.48 mm respec-
tively) compared to the baseline. This finding is in agree-
ment with Anderson,23 who reported that collagen barrier
treated sites had 87% of "approximate defect area" reso-
lution in furcation areas compared to 49% restoration in the
flap debridement control sites. In addition, several studies
have reported on these criteria with use of expanded pol-
ytetrafluoroethylene (ePTFE). Lekovic et al.24 showed only
0.12 mm horizontal fill at 6 month re-entry and Caffesse et
al.25 reported 1.4 mm gain. This comparison indirectly sug-
gests that collagen membrane may have better potential to
regenerate horizontal bone fill than the ePTFE non-absorb-
able membrane.
The major benefit of using a bioabsorbable collagen
membrane instead of ePTFE barriers is that collagen is a
natural protein of the human body which is degraded by
host enzymes, hence eliminating the need for a second re-
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Figure 3. Results of collagen membrane treatment. A. surgical exposure
of class II furcation defect with 5 mm vertical probing depth from the
alveolar crest and 5 mm of horizontal probing component; B. one-year
re-entry showing furcation filled with attached, dense, non-probeable tis-
sue as seen in e-PTFE treated cases.
trieval surgery. Thus, the possibility of losing attachment
gained through a GTR procedure by secondary surgery is
reduced.26 Also, animal studies by Pitaru et al.5 and Pfieffer
et al.4 demonstrated that collagen membranes can prevent
apical migration of epithelium and enhance new connective
tissue attachment during periodontal wound healing to the
same extent as ePTFE membranes.1 Although, statistically
significant gains in clinical attachment levels were not ob-
served in this present study, positive clinical trends were
observed for collagen membrane-treated sites. This obser-
vation agrees with a recent study by Blumenthal21 which
reported that both collagen membrane and ePTFE are ef-
fective in gaining vertical open probing new attachment and
horizontal open and closed probing new attachment. In ad-
dition, it was also reported that sites treated with collagen
membrane had less membrane exposure when compared to
ePTFE treated sites;21 we report similar findings in this
study. Lack of membrane exposure may be explained by
the fact that collagen is chemotactic for fibroblasts12 which
may enhance initial flap stabilization and the potential for
regeneration. This property may reduce the detrimental ef-
fects which we believed to accompany exposure of mem-
brane during GTR procedure and microbial colonization of
barrier materials following GTR therapy.3-27
Adverse tissue reaction, infections, or delayed healing
were not observed following surgical placement of a bioab-
sorbable collagen barrier in this study. The presence of the
collagen membrane did not increase plaque accumulation
or gingival inflammation (Table 1), even though a mild host
inflammatory response accompanied absorption of the
membrane. A previous study has demonstrated that the
presence of collagen membrane was not associated with
increased bacterial colonization and did not alter the local
microflora when compared to the flap debridement and un-
treated control sites.28 These findings are in agreement with
Blumenthal21 and are further supported by Choi et al.,29 who
reported that collagen matrix placed in a canine fenestration
wound neither enhances nor inhibits periodontal healing.
Also, Stein et al. showed that there were no adverse effects
on the adjacent healthy sites when a collagen membrane
was placed during GTR procedures.30 Kamer and Churu-
kian reported that 2% of patients receiving injectable col-
lagen experienced localized hypersensitivity reactions at the
site of injection.31 No such reaction was noted in patients
in this study. Johns et al. indicated that collagen membrane
placed during GTR procedures does not elicit an antibody
reaction.32 The low antigenicity of this product is likely
related to the fact that the collagen membrane is treated
with pepsin to remove its tyrosine (the most highly anti-
genic portion) content. Therefore, the product appears to be
a biocompatible and safe material. The collagen barrier
used in this study is easy to trim, adapt, and secure to the
defect. When compared to ePTFE membrane, the collagen-
treated sites tend to show better tissue response during early
wound healing.21 Since collagen is a hemostatic agent by
virtue of its ability to aggregate platelets, it may further
facilitate wound maturation by enhancing the initial blood
clot and fibrin linkage formation.8 This concept is supported
by Haney et al. who indicated that clot stabilization, wound
stability, space provision, epithelial cell exclusion, and
complete gingival coverage are critical factors for the suc-
cess of GTR procedures.10
A limitation of this study is the small sample size used;
this shortcoming may have some affect or influence the
power and significance of statistical tests used in this study.
Future studies should include a larger sample size and longer
follow-up time to determine the long-term effect of collagen
membrane treatment. Within the scope of this initial study,
the following conclusions can be drawn: 1) the placement of
type I bovine collagen membrane during surgery on Class II
furcations results in significantly higher defect fill and ver-
tical bone fill when compared to the control sites; 2) sites
treated with collagen membranes show a significant im-
provement in horizontal bone repair and defect improvement
when compared to the presurgical status; 3) the collagen
membrane-treated sites are twice as likely to have greater
than 50% vertical bone fill than the control sites; 4) no
significant differences were observed in attachment gain
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probing depth reduction, or mobility; 5) the collagen mem-
brane is well tolerated by the tissues with test and control
sites exhibiting comparable recession pattern, in general tis-
sue healing was similar to that observed following conven-
tional flap therapy; and 6) surgical treatment with or with-
out a collagen membrane showed significant improvement
in clinical parameters from baseline.
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